Carlos Roncero

Universitat Autònoma de Barcelona — Spain

Medicine · Health Sciences

37h-index5.3kcitations336works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(66), Attention Deficit Hyperactivity Disorder(57), Substance Abuse Treatment and Outcomes(53), Neurotransmitter Receptor Influence on Behavior(52), Opioid Use Disorder Treatment(39)

Publications335 total

Relevant Criteria for Improving Quality of Schizophrenia Spectrum Disorders Treatment: A Delphi Study
Healthcare·2025Open Access
PRISM-5 update: Adaptation and validation of the Spanish version interview for dual diagnosis assessment based on DSM-5 criteria
Spanish Journal of Psychiatry and Mental Health·2025
Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study
Psychopharmacology Bulletin·2025· 4 cited
Benzodiazepine Misuse Among Health Care Workers: The Effect of Sleep Disorders on Work Performance
Journal of Clinical Medicine·2025Open Access
Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use
Frontiers in Pharmacology·2025· 4 citedOpen Access
Age-Related Cognitive Decline in Substance Use Disorder: Impact of Prolonged Substance Consumption
European Psychiatry·2025Open Access
Cariprazine in multiple-episode dual schizophrenia: post-hoc analysis of an observational study
European Psychiatry·2025Open Access
The Relevance of Insomnia Among Healthcare Workers: A Post-Pandemic COVID-19 Analysis
Journal of Clinical Medicine·2025· 3 citedOpen Access
Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients
Frontiers in Psychiatry·2025· 2 citedOpen Access
Is there a risk of esketamine misuse in clinical practice?
Therapeutic Advances in Drug Safety·2025· 7 citedOpen Access
Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study
BMC Public Health·2024· 5 citedOpen Access
CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome
Frontiers in Neurology·2024· 1 citedOpen Access
Follow-up of telemedicine mental health interventions amid COVID-19 pandemic
Scientific Reports·2024· 4 citedOpen Access
Post-Pandemic Evolution of Suicide Risk in Children and Adolescents Attending a General Hospital Accident and Emergency Department
Healthcare·2024· 7 citedOpen Access
Prevalence of diabetes and insulin resistance in patients with diagnosis of schizophrenia or other psicotic disorders
European Psychiatry·2024Open Access
Dual disorder: does expert clinical experience support the rationale for cariprazine use?
PubMed·2024· 2 citedOpen Access
Post-COVID 19 Pandemic Evolution of Suicide Ideation and Self-harm Behaviour Rates among Children and Adolescents Attending an Accident and Emergency Department
Research Square (Research Square)·2024Open Access
Effectiveness of cariprazine in first-episode schizophrenia patients with comorbid cannabis use disorder: post-hoc analysis of a Spanish observational study
Neuroscience Applied·2024Open Access
CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE.
PubMed·2023Open Access
Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
Gastroenterología y Hepatología (English Edition)·2023· 2 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Miguel Casas(28), Lara Grau‐López(18), Constanza Daigre(16), Laia Rodríguez-Cintas(14), Josep Antoni Ramos‐Quiroga(10), Nieves Martínez‐Luna(8), Marta Ribasès(7), Jesús Pérez-Pazos(7), Carmen Barral(7), Elena Ros‐Cucurull(6), Begoña Gonzalvo(6), Cristina Sánchez‐Mora(5), Lourdes Aguilar(4), Hannu Alho(4), Xavier Castells(4), Sergi Valero(4), Rosa Bosch(4), Francisco José Eiroá‐Orosa(4), Noèlia Fernàndez‐Castillo(4), Bru Cormand(4)